Don’t want emails from us anymore? Click here to unsubscribe.

A sportswear giant is slipping after forecasting a deeper sales dip, a weight loss solutions firm is soaring 67% on promising trial results for its key product, and a healthcare giant is promising a $55B boost to the U.S. economy. Here’s all you need to know.

Disruptive Biotech (Sponsored)

Are you looking for a way to potentially boost your returns on Tesla stock?

Look no further than the GraniteShares YieldBoost TSLA ETF (TSYY).

Don't miss out on this opportunity to potentially enhance your Tesla investment.

TSYY offers a unique approach to generating income while maintaining exposure to one of the most talked-about stocks in the market.

Learn More.

Futures 📈

What to Watch

Earnings:

Economic Reports:

Disruptive Biotech (Sponsored)

Could This Small Biotech Trigger a Major Healthcare Shift?

A little-known biotech is developing a groundbreaking antiviral that may soon change how we fight global viruses—RSV, COVID, Influenza, and more.

With a Phase II trial just around the corner, this company is gaining serious attention for its broad-spectrum approach to viral treatment.

The science is promising, and early investors are positioning ahead of what could be a pivotal announcement.

If successful, this could be one of the most disruptive healthcare breakthroughs in years—and a rare chance to get in before Wall Street catches on.

Click here to get the full story behind this under-the-radar biotech before it breaks out.

Healthcare

J&J Unveils Major U.S. Investment Plan, Promises New Manufacturing Sites and R&D Boost

Johnson & Johnson (NYSE: JNJ) announced a sweeping $55 billion investment initiative across the United States over the next four years, marking a 25% increase over its prior domestic spending.

The healthcare giant says the plan includes the construction of four new manufacturing plants and expansions at several existing sites.

The first project kicks off today in Wilson, North Carolina, as the company breaks ground on a state-of-the-art facility expected to produce advanced therapies and create new American jobs.

Chairman and CEO Joaquin Duato stated that the move reflects the company’s confidence in U.S. innovation and manufacturing strength.

The initiative also includes sizable allocations for research and development, as well as technological infrastructure upgrades.

The company projects that the investments will generate an annual economic impact of over $100 billion nationwide.

While locations for the remaining three new facilities have not yet been disclosed, the announcement aligns Johnson & Johnson with a broader trend of domestic investment among major corporations.

Earlier this year, Taiwan Semiconductor Manufacturing Co. announced a $100-billion U.S. expansion, and Apple pledged over $500 billion in U.S. investments, including a major factory in Houston set to open in 2026.

J&J’s expansion highlights the ongoing momentum among global firms to reinforce their U.S. manufacturing footprint amid shifting economic and geopolitical dynamics.

Sportswear

Nike Warns of Further Sales Dip, Shares Slide Nearly 6% Premarket

Nike’s (NYSE: NKE) stock is down nearly 6% in early U.S. trading this morning after the company projected another quarter of revenue decline, shaking investor confidence in its ongoing turnaround efforts under new CEO Elliott Hill.

On Thursday, the athletic apparel giant cautioned that fourth-quarter revenue would fall more than previously anticipated.

The warning followed a 17% drop in China sales last quarter, pointing to persistent consumer caution despite promotional efforts.

Hill, who stepped into the CEO role in October, has introduced a “Win Now” initiative aimed at regaining momentum in key markets such as Shanghai and Beijing.

While expedited launches of models like the Pegasus Premium and Vomero 18 helped lift third-quarter sales, analysts remain skeptical about the speed of recovery.

Nike’s CFO Matthew Friend said the company still has multiple quarters of inventory cleanup ahead, which will require aggressive discounting and likely squeeze margins.

Analysts from Barclays and Zacks noted that rebuilding retail partnerships and refreshing product innovation will take time, with a full turnaround not expected until at least the second half of fiscal 2026.

Since Hill’s appointment, Nike shares have slipped 11%, erasing the post-announcement rally.

Critical Minerals (Sponsored)

This Junior Uranium Stock Could Be Set for a Big Run

Uranium markets are heating up—and billionaire investors like Bill Gates, Jeff Bezos, and Sam Altman are already all-in on the next wave of nuclear energy.

With 90% of America’s uranium imported, the U.S. is in desperate need of domestic and regional supply—and Canada’s uranium-rich regions are front and center.

One small-cap uranium company with assets in the prolific Athabasca Basin and Central Mineral Belt could be in the perfect position. With drilling in progress and rising institutional interest, the setup looks strikingly similar to where UEC was before it soared 2,500%.

If you missed the 2,500% run of UEC, now’s your chance to get in early on what could be the sector’s next breakout.

Get the name and symbol here.

Electric Vehicles

Disappointing Outlook from NIO Sparks Selloff Across China’s EV Sector

Shares of Chinese electric vehicle makers are trading sharply lower this morning because NIO Inc.’s (NYSE: NIO) fourth-quarter loss has widened.

The firm has also issued revenue guidance that is below Wall Street projections.

NIO’s U.S.-listed stock is down 3.4% in premarket trading as the company reported a quarterly net loss of RMB7.13 billion ($990 million), up from RMB5.59 billion a year earlier.

The automaker expects first-quarter revenue between RMB12.4 billion ($1.69 billion) and RMB12.8 billion ($1.76 billion), significantly below analyst expectations of $2.31 billion.

Vehicle deliveries are forecasted to grow 36% year-over-year to a range of 41,000 to 43,000 units, but the pace marks a slowdown compared to previous quarters.

CEO William Bin Li called 2025 a pivotal year, with new launches planned across all three of the company’s brands.

While the premium NIO lineup will focus on tech innovation, the ONVO sub-brand is targeting the mass market with broader offerings.

Meanwhile, Firefly’s debut model is scheduled to begin deliveries in April, aiming to support global expansion.

The cautious tone dragged down peer stocks, with XPeng falling 3.3% and Li Auto off 2.7% ahead of the market open.

Investors appear concerned over softening demand and heightened competition within China’s EV landscape.

Allurion Technologies, Inc. [ALUR] - Last Close: $2.28

Allurion Technologies is a health-tech company specializing in non-invasive weight loss solutions, most notably the Allurion Balloon, a swallowable gastric balloon designed for safe and temporary weight reduction.

Its shares are soaring 67% in premarket trading after the firm announced strong initial trial results for its gastric balloon, when combined with the weight-loss drug semaglutide.

Patriot National Bancorp Inc. [PNBK] - Last Close: $1.06

Patriot National Bancorp is a community-focused bank.

Shares of the bank are soaring 35% during early trading after the company announced the departure of CEO David Lowery and a $50 million private placement to boost its equity capital and balance sheet stability.

Snow Lake Resources Ltd. [LITM] - Last Close: $0.60

Snow Lake Resources is a North American uranium exploration company. Though still pre-revenue, it holds strategic assets like the Pine Ridge Uranium Project in Wyoming and recently pivoted into uranium from lithium, aligning itself with growing nuclear energy demand.

Its stock is up nearly 12% in premarket trading after the Trump administration issued an executive order to accelerate U.S. mineral production, including uranium.

Next-Gen Display (Sponsored)

This MicroLED Innovator Could Follow OLED’s 4,090% Path

OLED’s rise from a $6 IPO to a $252 stock created life-changing returns—4,090% to be exact.

Now, all eyes are on the next big shift in display tech: MicroLED.

One low-float company is gaining serious traction, with patented production technology and a major partnership that could fast-track mass commercialization.

With the market expected to surpass $21 billion by 2027, early investors are taking notice.

Get the name and full report now, before this story hits the mainstream.

Everything Else

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club